home / stock / agrx / agrx news


AGRX News and Press, Agile Therapeutics Inc. From 08/11/22

Stock Information

Company Name: Agile Therapeutics Inc.
Stock Symbol: AGRX
Market: OTC
Website: agiletherapeutics.com

Menu

AGRX AGRX Quote AGRX Short AGRX News AGRX Articles AGRX Message Board
Get AGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

AGRX - Agile Therapeutics GAAP EPS of -$2.71 beats by $0.99, revenue of $2.1M beats by $0.12M

Agile Therapeutics press release ( NASDAQ: AGRX ): Q2 GAAP EPS of -$2.71 beats by $0.99 . Revenue of $2.1M (+75.0% Y/Y) beats by $0.12M . “Our goals as a company are to grow our Twirla brand and become cash flow positive. We believe we took important ste...

AGRX - Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Second Consecutive Quarter of Increase in Twirla Demand and Decrease in Company Operating Expenses Cash on Hand Expected to Fund Operations Through 2022 Company Announces Twirla ® Product Supply Agreement with Nurx Management to Host Conference ...

AGRX - Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022

PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after the market close on Thursday, August 11, 2022. Following the release, the Company wi...

AGRX - Circling Back On Agile Therapeutics

Today, we revisit a small biopharma called Agile Therapeutics for the first time in a year and a half. The company recently addressed its short-term funding needs, and its Twirla contraception patch seems to be gaining some traction. An investment analysis follows in the paragraph...

AGRX - Agile Therapeutics updates Q2 guidance

Agile Therapeutics ( NASDAQ: AGRX ) updated its Q2 Twirla demand (total cycles) and operating expense guidance that was initially provided on May 24, 2022. Twirla demand is now seen to be at the mid-point of the earlier provided range (20K to 22K) of 21K to 21.5K...

AGRX - Agile Therapeutics Updates Second Quarter 2022 Guidance

Twirla® Demand Guidance (Total Cycles) Expected to be at Midpoint of Guided Range Operating Expenses (OPEX) Expected to be Below Guided Range PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company,...

AGRX - Agile gains as H.C. Wainwright sees 630% upside potential

Agile Therapeutics ( NASDAQ: AGRX ) rose sharply in the early trading on Monday after H.C. Wainwright doubled the price target on the women's healthcare company to a Street high of $5.00 citing its prospects following the recent Supreme Court ruling on abortion rights. ...

AGRX - Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch

Penny Stocks To Buy If you want to make money in the stock market today and do it quickly, penny stocks might be on your watch list. According to the definition, we’re talking about stocks trading below $5. But for some, they look for much cheaper stocks to buy. Penny Stocks ...

AGRX - Agile Therapeutics to Participate in Maxim Group's Upcoming Women's Health Panel

PRINCETON, N.J., July 08, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be participating in a virtual panel discussion presented by Maxim Group LLC and hosted by M-Vest. Full detail...

AGRX - What to Know About Buying Penny Stocks on July 7th 

Buying Penny Stocks on July 7th, Here’s What You Need to Know If you’re buying penny stocks on July 7th, there is a lot that you need to know. For starters, we know that volatility is at a very high level right now. And, that is not something that many believe will change ...

Previous 10 Next 10